Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay; Jan Deenan; Silvia Bertagnolio; Charles Boucher; Francoise Brun-Vezinet; Bonaventura Clotet; Carlo Giaquinto; Carlo F. Perno

doi:10.3851/IMP2650

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay, Jan Deenan, Silvia Bertagnolio, Charles Boucher, Francoise Brun-Vezinet, Bonaventura Clotet, Carlo Giaquinto, Carlo F. Perno

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

12 Cites (Scopus)

Resum

Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. © 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).

Idioma original	Anglès
Pàgines (de-a)	831-836
Revista	Antiviral Therapy
Volum	18
Número	6
DOIs	https://doi.org/10.3851/IMP2650
Estat de la publicació	Publicada - 1 de des. 2013

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

ODG 3 – Bona salut i benestar

Accés al document

10.3851/IMP2650

Altres arxius i enllaços

https://www.scopus.com/pages/publications/84890364624

Com citar-ho

Pillay, D., Deenan, J., Bertagnolio, S., Boucher, C., Brun-Vezinet, F., Clotet, B., Giaquinto, C., & Perno, C. F. (2013). Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antiviral Therapy, 18(6), 831-836. https://doi.org/10.3851/IMP2650

@article{0e93095253234e13859eb78ed59ee521,

title = "Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network",

abstract = "Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. {\textcopyright} 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).",

author = "Deenan Pillay and Jan Deenan and Silvia Bertagnolio and Charles Boucher and Francoise Brun-Vezinet and Bonaventura Clotet and Carlo Giaquinto and Perno, \{Carlo F.\}",

year = "2013",

month = dec,

day = "1",

doi = "10.3851/IMP2650",

language = "English",

volume = "18",

pages = "831--836",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "6",

}

Pillay, D, Deenan, J, Bertagnolio, S, Boucher, C, Brun-Vezinet, F, Clotet, B, Giaquinto, C & Perno, CF 2013, 'Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network', Antiviral Therapy, vol. 18, núm. 6, pàg. 831-836. https://doi.org/10.3851/IMP2650

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. / Pillay, Deenan; Deenan, Jan; Bertagnolio, Silvia et al.
In: Antiviral Therapy, Vol. 18, Núm. 6, 01.12.2013, pàg. 831-836.

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

TY - JOUR

T1 - Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

AU - Pillay, Deenan

AU - Deenan, Jan

AU - Bertagnolio, Silvia

AU - Boucher, Charles

AU - Brun-Vezinet, Francoise

AU - Clotet, Bonaventura

AU - Giaquinto, Carlo

AU - Perno, Carlo F.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. © 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).

AB - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. © 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).

UR - https://www.scopus.com/pages/publications/84890364624

U2 - 10.3851/IMP2650

DO - 10.3851/IMP2650

M3 - Article

SN - 1359-6535

VL - 18

SP - 831

EP - 836

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 6

ER -

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Resum

SDG de les Nacions Unides

Accés al document

Altres arxius i enllaços

Fingerprint

Com citar-ho